Hormone: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 23: | Line 23: | ||
* [[Vascular Endothelial Growth Factor Receptor]] | * [[Vascular Endothelial Growth Factor Receptor]] | ||
* [[Receiver domain of sensor histidine kinase CKI1]] | * [[Receiver domain of sensor histidine kinase CKI1]] | ||
* [[Beta-2 Adrenergic Receptor]] | |||
}} | }} | ||
| Line 35: | Line 36: | ||
==Additional 3D Structures of Hormones and Hormone Receptors and Related Molecules== | ==Additional 3D Structures of Hormones and Hormone Receptors and Related Molecules== | ||
===Adrenaline=== | |||
[[Beta-2 Adrenergic Receptor]]<br /> | |||
[[Adrenergic receptor]]<br /> | |||
===Angiotensinogen=== | ===Angiotensinogen=== | ||
[[2wxw]], [[2wxx]], [[2wxy]], [[2wxz]], [[2wy0]], [[2wy1]], [[2x0b]] - Angiotensinogen – human, rat, mouse<br /> | [[2wxw]], [[2wxx]], [[2wxy]], [[2wxz]], [[2wy0]], [[2wy1]], [[2x0b]] - Angiotensinogen – human, rat, mouse<br /> | ||